Search Filters

Sponsors/Funders See All +

Phase See All +

Medical Condition See All +

Medicine See All +

This is a keyword search. It will find studies with your keywords in the study information.
To find studies using the keyword search, enter your keyword search term below, e.g. "lung cancer" or a trial identification number.
You can also search studies by Sponsor/Funder, Phase, Medical Condition or Medicine by using the search filters on the left.

Keyword Search Clear All

To initiate a Research Proposal or to Ask a Question about studies, please do the following:

Login and create an account.
Click on the Study ID to view Study Details.
If you cannot find the specific study you are looking for, click here to submit an Enquiry

Export All Studies >

3043 Results:

Sponsor	Studies ↑	Description	Ready to Share	Created

Astellas	ASTELLAS-015K-CL-PS01	A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Sequential Group, Multiple-Dose Escalation Study to Evaluate the Efficacy and Safety of ASP015K in Subjects with Moderate to Severe Plaque Psoriasis	No	3/31/2020

Astellas	ASTELLAS-015K-CL-RA21	A Phase 2b, Randomized, Double-blind, Parallel-group, Placebo controlled, Dose-finding, Multi-center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis in Patients who have had an Inadequate Response to Methotrexate	No	2/18/2020

Astellas	ASTELLAS-015K-CL-RA22	A Phase 2b, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding, Multi-center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Patients	No	2/18/2020

Astellas	ASTELLAS-015K-CL-RA25	A Phase 2 Open-label, Noncomparative, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study	No	2/18/2020

Astellas	ASTELLAS-015K-CL-RAJ1	Phase 2b Study of ASP015K – A Double-Blind, Placebo-Controlled, Dose-Finding Study in Moderate to Severe Rheumatoid Arthritis Patients –	No	7/14/2020

Astellas	ASTELLAS-015K-CL-RAJ3	Phase 3 Study of ASP015K - A Randomized, Double-blind, Placebo-controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis Who Had an Inadequate Response to DMARDs -	No	7/14/2020

Astellas	ASTELLAS-015K-CL-RAJ4	Phase 3 Study of ASP015K - A Randomized, Double-blind, Placebo-controlled Confirmatory Study of the Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis Who Had an Inadequate Response to MTX -	No	7/14/2020

Astellas	ASTELLAS-0456-CL-1021	Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Chronic Constipation (Not Including Constipation Due to Organic Diseases)	No	2/28/2020

Astellas	ASTELLAS-0456-CL-1031	Phase 3 Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study and an Open-label, Uncontrolled, Long-term Dosing Study in Patients with Chronic Constipation (Not Including Constipation Due to Organic Diseases) -	No	2/28/2020

Astellas	ASTELLAS-1707-CL-0011	A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Efficacy, Safety, and Dose-Response Relationship of ASP1707 in Subjects with Endometriosis Associated Pelvic Pain for 12 Weeks, Followed by a 12-Week Double-blind Extension without Placebo Control, Including a 24-Week Open-Label Leuprorelin Acetate Treatment Group for Bone Mineral Density Assessment	No	2/18/2020

First 1 2 3 4 5 ... Last